Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Posted in Product Liability

On November 19,  in open federal court in Toledo, Ohio, Johnson & Johnson agreed to pay at least $2.475 billion to settle thousands of lawsuits over its recalled hip implants.

Johnson & Johnson Settlement Details

Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals unit lost a jury trial in Philadelphia over its drug Topamax. The jury ordered the companies to pay $11 million in a product liability lawsuit which claimed that the anti-seizure drug Topamax caused birth defects.

Dallas Defective Medical Device attorneyJury: Failure to Warn

Jurors in state court in Philadelphia found that Janssen failed to adequately warn doctors for Haley Powell, of the risks of Topamax before she gave birth to a son with a cleft lip.

There has been many warnings issued to health departments world wide about potential problems with Smith & Nephew’s Birmingham metal-on-metal hip replacements. These hip model and others including the R3 model, have been linked to a high failure rate according to implant registry data in Europe and Australia.

metal on metal hip injury attorneySmith & Nephew recently issued a safety notice that indicates the Birmingham hip failure rate appears to be higher than 1%, which exceeds the rate established for quality standards according to the United Kingdom’s National Institute for Health and Clinical Excellence.

According to data collected since 2010 in the National Joint Registry of England and Wales, as well as the Australian Orthopaedic Associations National Joint Replacement Registry, the rate of Smith & Nephew Birmingham hip problems that were classified as a failure were 1.29% and 1.12%, respectively.

Today in open federal court in Toledo, Ohio, Johnson & Johnson agreed to pay at least $2.47 billion to settle thousands of lawsuits over its recalled hip implants. The agreement would settle about 8,000 U.S. suits against J&J’s DePuy unit brought by patients who have already had artificial hips removed. The company will pay an average of about $250,000 for each surgery and cover related medical costs.

Johnson & Johnson Under Fire from Lawsuits

The settlement is the second multibillion-dollar settlement this month for J&J. The company, agreed November 4 to pay $2.2 billion to resolve criminal and civil probes into the marketing of Risperdal and other medicines.

For the folks who have been injured or severely maimed by the defective Depuy ASR metal on metal hip implant, relief is around the corner. According to unnamed sources, Bloomberg News and the New York Times, a mammoth settlement is pending release in open federal court on Tuesday November 19th.

The proposed settlement is going to be presented in federal court and will need the blessing of the federal judge overseeing the DePuy ASR litigation, which at last count has passed the 12,000 mark for folks afflicted by the allegedly faulty hip implant.

According to Bloomberg News, Johnson & Johnson (JNJ) will pay more than $4 billion to resolve the product liability lawsuits over its recalled hip implants. This massive settlement is the largest of U.S. lawsuit claims over an allegedly defective medical device, and affects thousands of patients who have been injured by the metal on metal hip implant.

Settlement Impacts Thousands of Patients

Our law firm recently filed a product liability lawsuit against C.R. Bard, which claims that one of the company’s IVC (inferior vena cava, is a major vein that runs the length of the body from the heart down to the leg) filters failed. The Bard IVC filter has cut into the walls of the woman’s vena cava and it cannot be removed without major invasive surgery.

Robin Arnold and her husband, Felix, filed her case in the U.S. District Court for the Western District of Texas. They filed claims against Bard for negligence, failure to warn, design defects, manufacturing defects, breach of implied warranty, negligent misrepresentation and loss of consortium.

According to a Maryland jury, Takeda Pharmaceutical Co. failed to properly warn about the risks of its Actos diabetes drug and ordered the company to pay more than $1.7 million in damages. This was the second state court Actos bladder case injury case to go to trial. The judge overseeing the case immediately threw out the verdict.

Actos_Bladder_Cancer_Attorney-thumbActos Bladder Cancer: The Jury Speaks

According to Bayer, the pharmaceutical giant has paid out more than $1.6 billion in settlements over Yasmin and Yaz blood clot embolism injuries. The German drug manufacturer is exposed to thousands of product liability drug claims that allege that women suffered severe blood clots due to dangerous side effects of the birth control pills. Bayer has been settling these injury cases over the past 2 years.

Bayer 3rd Quarter Report

Contact Information